Clinical Trial Update: Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of an insulin sensitizer with leptin for HAART-induced metabolic syndrome in HIV lipodystrophy; the study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Lipodystrophy
• Metabolic Syndrome

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: HIV Lipodystrophy | Phase 2 | Status: COMPLETED | Results posted: 2017-03-23